Publications
5677 Results
- Journal / Conference
- ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), poster
- Year
- 2024
- Research Committee(s)
- Leukemia
4q Copy Neutral Loss of Heterozygosity and KMT2A Partial Tandem Duplication Identified By Chromosomal Genomic Array Testing (CGAT) Correlated with Decreased Overall Survival in Acute Myeloid Leukemia (AML)
- Journal / Conference
- ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), oral
- Year
- 2024
- Research Committee(s)
- Lymphoma
Lack of benefit of autologous hematopoietic cell transplantation (auto-HCT) in mantle cell lymphoma (MCL) patients (pts) in minimal residual disease (MRD)-negative first complete remission (CR): Initial report from ECOG-ACRIN EA4151
- Journal / Conference
- ASH Annual Meeting (December 7-10, 2024, in San Diego, CA), poster
- Year
- 2024
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/A052101
Trial in Progress – Alliance A052101: A randomized phase 3 trial of continuous vs. intermittent maintenance therapy with zanubrutinib as upfront treatment in older patients with mantle cell lymphoma
- Journal / Conference
- ABRCMS 2024 Graduate Symposium (Nov. 13-16 in Pittsburgh, PA), poster
- Year
- 2024
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
Outcome and Treatment Toxicity at Community versus Academic Sites for Patients with Rare Cancers on Immune Checkpoint Inhibitors (NCI/SWOG S1609)
- Journal / Conference
- Journal of the National Cancer Institute
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39180477
- PMC
- PMC11630502
- Study Number(s)
- CTSU/C80702
Inflammation, Physical Activity, and Disease-Free Survival in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
- Journal / Conference
- Haematologica Jan 1;108(1):42-47
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID35833298
- PMC
- PMC9827148
- Study Number(s)
- S0106, S1203, SWOG-8600, SWOG-9031
Improved outcomes with 7+3 induction chemotherapy for acute myeloid leukemia over the past four decades: Analysis of SWOG trial data
- Journal / Conference
- Journal of Clinical Oncology 10;41(2):336-342
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID35787017
- PMC
- PMC9839232
- Study Number(s)
- S0016, S0801
Relevance of bone marrow biopsies for response assessment in U.S. National Cancer Institute National Clinical Trials Network follicular lymphoma clinical trials
- Journal / Conference
- Journal of Clinical Oncology Jan 20;41(3):472-478
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36067452
- PMC
- PMC9870237
- Study Number(s)
- CTSU/C80405
Acquired Genomic Alterations on First Line Chemotherapy with Cetuximab/Bevacizumab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of CALGB/SWOG-80405 Trial
- Journal / Conference
- Annals Surgical Oncology Feb;30(2):1099-1109
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36305992
- PMC
- PMC9807536
Phase III Prospectively Randomized Trial of Perioperative 5-FU after Curative Resection, Followed by 5-FU/Leucovorin for Patients with Colon Cancer- Intergroup: A trial of the ECOG-ACRIN Research Group (E1292)
- Journal / Conference
- Journal of Clinical Oncology Jan 20;41(3):590-598
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36228177
- PMC
- PMC9870230
- Study Number(s)
- S1415CD